Online Training for the Reconstitution of Fosun/BioNTech

计划入组 385 人 · 首次发布于 2022 年 4 月 8 日

Exacerbations and Their Outcomes International (EXACOS International)

计划入组 1,762 人 · 首次发布于 2021 年 6 月 16 日

Exacerbations and Their Outcomes International (EXACOS International)

计划入组 3,477 人 · 首次发布于 2023 年 3 月 2 日

Tetanus vaccines(Shanghai Fosun Pharmaceutical)

Venezuelan equine encephalitis VLP-based vaccine (SRI International/USAMRIID)

B2D (SRI International)

Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.

China

Sealand Securities Co. Ltd

FOSUN INDUSTRIAL CO., LIMITED

Hong Kong, China

AIM Vaccine's mRNA RSV Vaccine Advances to U.S. Clinical Trials with Superior Preclinical Results

Fosun Pharma and MingMed Achieve Key Regulatory Milestones for Novel Therapies

Fosun Pharma's Innovative Drug Receives Registration Acceptance in China